Mariner, LLC Abbott Laboratories Transaction History

Mariner, LLC

$55.8 Billion
Q3 2024

A detailed history of Mariner, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Mariner, LLC holds 1,260,085 shares of ABT stock, worth $146 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

1,260,085

Previous 1,400,045 10.0%

Holding current value

$146 Million

Previous $145 Million 1.25%

% of portfolio

0.26%

Previous 0.28%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $14 Million - $16.5 Million	-139,960 Reduced 10.0%	1,260,085 $144 Million
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $7.33 Million - $8.19 Million	72,813 Added 5.49%	1,400,045 $145 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $11 Million - $12.2 Million	100,844 Added 8.22%	1,327,232 $151 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $6.17 Million - $7.55 Million	68,430 Added 5.91%	1,226,388 $135 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $1.45 Million - $1.74 Million	-15,204 Reduced 1.3%	1,157,958 $112 Million
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $10.7 Million - $11.9 Million	-106,121 Reduced 8.3%	1,173,162 $128 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $5.16 Million - $6.07 Million	53,272 Added 4.35%	1,279,283 $130 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $5.36 Million - $6.28 Million	56,356 Added 4.82%	1,226,011 $135 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $12.3 Million - $14.3 Million	127,563 Added 12.24%	1,169,655 $113 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $5.7 Million - $6.89 Million	55,862 Added 5.66%	1,042,092 $113 Million
Q1 2022 May 13, 2022	BUY	$114.02 - $139.04 $14.6 Million - $17.9 Million	128,406 Added 14.97%	986,230 $117 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $20.3 Million - $24.9 Million	175,965 Added 25.81%	857,824 $121 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $6.45 Million - $7.14 Million	55,328 Added 8.83%	681,859 $80.5 Million
Q2 2021 Aug 24, 2021	BUY	$105.79 - $124.53 $4.9 Million - $5.76 Million	46,284 Added 7.98%	626,531 $72.6 Million
Q1 2021 May 07, 2021	BUY	$108.84 - $128.23 $2.62 Million - $3.09 Million	24,068 Added 4.33%	580,247 $69.5 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $8.66 Million - $9.44 Million	82,487 Added 17.41%	556,179 $60.9 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $937,660 - $1.14 Million	10,232 Added 2.21%	473,692 $51.5 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $2.29 Million - $2.94 Million	29,954 Added 6.91%	463,460 $42.4 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $6.7 Million - $9.8 Million	106,643 Added 32.63%	433,506 $34.2 Million
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $8.09 Million - $9.01 Million	-103,071 Reduced 23.97%	326,863 $28.4 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $16.4 Million - $17.8 Million	-200,377 Reduced 31.79%	429,934 $36 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $3.17 Million - $3.7 Million	43,557 Added 7.42%	630,311 $53 Million
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $22.5 Million - $27.2 Million	339,973 Added 137.76%	586,754 $46.9 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $8.03 Million - $9.1 Million	122,488 Added 98.55%	246,781 $17.8 Million
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $1.78 Million - $2.15 Million	-29,288 Reduced 19.07%	124,293 $9.12 Million
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $5.42 Million - $5.98 Million	94,140 Added 158.38%	153,581 $9.37 Million
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $1.25 Million - $1.42 Million	22,255 Added 59.85%	59,441 $3.56 Million
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $650,977 - $696,938	12,127 Added 48.39%	37,186 $2.12 Million
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $1.2 Million - $1.34 Million	25,059	25,059 $1.34 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.31B

Call Options Held

8.74M

Put Options Held

7.89M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account